Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration-resistant prostate cancer.

Xiaoliang ChenJinghui LiuLijun ChengChaohao LiZhuangzhuang ZhangYunfeng BaiRuixin WangTao HanChangkun HuangYifan KongFeng FengXiaoqi Liu

Published in: The Prostate (2019)

The noncanonical Wnt pathway is activated in enzalutamide-resistant PCa and inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance and enhances its efficacy in CRPC.

Keyphrases

prostate cancer
cell proliferation
stem cells